Management discusses the positive topline results from the Phase 3 TIVO-3 Trial on a conference call to be held on November 5 at 5 pm.
Webast: https://edge.media-server.com/m6/p/z5kf53i5
https://thefly.com/landingPageNews.php?id=2817843
https://thefly.com/landingPageNews.php?id=2817843
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.